Provided By GlobeNewswire
Last update: Nov 11, 2025
Agreement creates runway for Profound’s incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East
Read more at globenewswire.comNASDAQ:PROF (11/17/2025, 8:10:23 PM)
6.46
-0.39 (-5.69%)
Find more stocks in the Stock Screener


